2.83
Accendra Health Inc stock is traded at $2.83, with a volume of 617.28K.
It is up +4.43% in the last 24 hours and down -18.21% over the past month.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
See More
Previous Close:
$2.71
Open:
$2.69
24h Volume:
617.28K
Relative Volume:
0.71
Market Cap:
$216.73M
Revenue:
$4.72B
Net Income/Loss:
$-123.85M
P/E Ratio:
-0.1979
EPS:
-14.2981
Net Cash Flow:
$-303.12M
1W Performance:
-2.75%
1M Performance:
-18.21%
6M Performance:
-82.02%
1Y Performance:
-82.02%
Accendra Health Inc Stock (ACH) Company Profile
Name
Accendra Health Inc
Sector
Industry
Phone
(804) 277-4304
Address
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ACH
Accendra Health Inc
|
2.83 | 207.54M | 4.72B | -123.85M | -303.12M | -14.30 |
|
MCK
Mckesson Corp
|
766.08 | 92.14B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
274.91 | 51.64B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
200.68 | 46.98B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
74.21 | 8.37B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
1.53 | 1.29B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Downgrade | UBS | Buy → Neutral |
| Jul-19-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-12-22 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-12-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-26-22 | Resumed | Citigroup | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-30-22 | Resumed | JP Morgan | Underweight |
| Mar-23-22 | Upgrade | HSBC Securities | Reduce → Hold |
| Apr-08-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-21 | Upgrade | Goldman | Sell → Buy |
| Dec-17-20 | Upgrade | UBS | Neutral → Buy |
| Sep-25-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| May-05-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Jan-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-07-20 | Downgrade | Goldman | Neutral → Sell |
| Nov-15-19 | Upgrade | CLSA | Underperform → Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-10-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-03-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-01-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Jan-18-19 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-15-19 | Upgrade | CLSA | Underperform → Outperform |
| Dec-14-18 | Downgrade | Morgan Stanley | Overweight → Underweight |
| Dec-12-18 | Downgrade | Goldman | Buy → Neutral |
| Sep-28-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-11-18 | Downgrade | CLSA | Outperform → Sell |
| Apr-10-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-26-18 | Upgrade | Goldman | Sell → Neutral |
| Nov-02-17 | Downgrade | HSBC Securities | Buy → Hold |
| Mar-24-16 | Upgrade | Goldman | Sell → Neutral |
| Dec-07-15 | Downgrade | Goldman | Neutral → Sell |
| Aug-31-15 | Upgrade | Credit Suisse | Underperform → Neutral |
| Aug-01-12 | Initiated | HSBC Securities | Underweight |
| Aug-05-09 | Upgrade | Citigroup | Sell → Buy |
| Dec-01-08 | Downgrade | HSBC Securities | Neutral → Underweight |
View All
Accendra Health Inc Stock (ACH) Latest News
Accendra Health launches debt exchange offer, seeks new financing - Investing.com UK
Accendra Health launches debt exchange offer, seeks new financing By Investing.com - Investing.com South Africa
Accendra Health Launches Major Debt Exchange and Refinancing Plan - TipRanks
Accendra Health launches exchange offers to replace 2029/2030 notes with new secured notes, $326.25M new-money first-lien issue - TradingView
Accendra Health Announces Offers and Consent Solicitations - Yahoo Finance
Accendra Health (ACH) Edges Higher: Key Levels to Watch After +2.77% GainDiagonal Spread Trade - Newser
Owens & Minor Launches Halyard Kitting - Yahoo Finance
Accendra Health (ACH) shares jump after first-quarter earnings beat - MSN
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Accendra Health, Inc. 8-K Filing Details: Company Information, Address, and Voting Results (May 14, 2026) - Minichart
Accendra Health Shareholders Approve Amended Omnibus Incentive Plan - TipRanks
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Accendra Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:ACH) 2026-05-14 - Seeking Alpha
Owens & Minor Names Chief Operating Officer - Yahoo Finance
ACCENDRA HEALTH INCANNOUNCES OVER $1.5 BLN BALANCE SHEET OPTIMIZATION DEAL - Moomoo
Accendra Health 1Q Adj Loss/Shr 4c >ACH - Moomoo
Accendra Health Q1 2026 slides: margins surge post-split, debt cut - Investing.com India
Accendra Health Inc (ACH) Q1 2026 Earnings Call Highlights: Navi - GuruFocus
Accendra Health To Effectuate Balance Sheet Optimization Transaction in Near Term >ACH - Moomoo
Accendra Health Reports Q1 2026 Financial Results and Announces $1.5 Billion Balance Sheet Optimization Transaction - Minichart
Accendra Health Shares Gain on Narrowed Loss, Adjusted EPS Beat - Moomoo
Accendra Health Q1 2026 slides: margins surge post-split, debt cut By Investing.com - Investing.com South Africa
Accendra Health cuts debt by $100M, extends maturities, but slow growth keeps EBITDA outlook cautious. - Pluang
Healthcare Firm Accendra Inks Discount Debt Exchange, New Funds - Bloomberg.com
Accendra Health Makes Progress Addressing Its Debt Load (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Q1 2026 Earnings Transcript - AOL.com
Accendra Health earnings beat by $0.06, revenue fell short of estimates - Investing.com Nigeria
Accendra Health 2026: Leading Home-Based Care Provider with Strong Financials, Growth Strategy, and Capital Structure Optimization - Minichart
Accendra Health 1Q 2026: Revenue $627.78M, EPS ($0.08) — 10-Q Summary - TradingView
Accendra Health (ACH) Q1 2026 loss, payor exit and major debt refi plan - Stock Titan
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 - Investing.com UK
Accendra Health (ACH) Q1 Earnings Show Mixed Results - GuruFocus
Accendra Health (ACH) Shares Jump After First-Quarter Earnings Beat - Yahoo Finance
Accendra Health 1Q Loss/Shr 8c >ACH - Moomoo
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 By Investing.com - Investing.com South Africa
Accendra Health reports Q1, announces $1.5B optimization - HME News
Accendra Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Accendra Health reports Q1 EPS (4c) vs. 29c last year - TipRanks
Q1 2026 Accendra Health Inc Earnings Call Transcript - GuruFocus
Accendra Health (NYSE:ACH) Beats Q1 Estimates and Unveils $1.5B Debt Restructuring - ChartMill
Accendra Health Reports Q1 Loss, Launches Balance Sheet Plan - TipRanks
Accendra Health stock soars nearly 10% on first quarter earnings beat - Investing.com Australia
Accendra Health stock soars nearly 10% on first quarter earnings beat By Investing.com - Investing.com South Africa
Accendra Health (ACH) reworks debt with $326M 9% notes, $300M revolver and exchanges - Stock Titan
Accendra Health (NYSE: ACH) unveils $1.5B balance sheet overhaul with Q1 results - Stock Titan
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction - marketscreener.com
Accendra Health Inc Stock (ACH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):